thetaOwl
HomeOptionsNVDAReports

NVDA

NVIDIA CorporationClose $205.19EOD only
Max Pain
$205.00
Next expiry Jun 15, 2026
Expected Move
±$3.93
1.9% from close
Price Gap
-0.19
Distance to max pain
IV Rank
49
Middle-high premium
P/C OI
0.85
Slightly call-heavy
Consensus
7.0/10
Bullish tilt
Published snapshot: Jun 12, 2026 close
End-of-day snapshot

This page reflects NVDA options positioning from the latest published market-close snapshot. Intraday price and contract changes are not displayed.

Published Snapshot
Jun 12, 2026 close
NVDA AI Consensus Report
Analysis based on market close June 15, 2026
DirectionalTheta GangFlowEarningsConsensus

Historical consensus-supported lens with full content, report chain context, and metric rail.

Conviction
7.5

out of 10

7.5 not 8.5 because while all personas align on bullish bias, the pinning vs breakout conflict and gamma flip risk at $200 cap certainty; if spot holds above $205 through expiry, conviction rises.

Where Perspectives Agree

Bullish pin to $205-$220 with dealer gamma support, flow accumulation, and theta-rich environment reinforcing upside bias.

Where They Diverge

Directional sees breakout to $220, but earnings warns pinning risk from spot above max pain ($205) and call OI wall at $230-$250 limits upside potential.

Top Trade
via theta

Sell 2026-07-17 $200/$195 put spread for $0.65 credit

Key Risk

Break below $200 flips dealer gamma long, removing support; downside accelerates to $190 or lower.

How to Use These Reports
This ai consensus reflects the market close on June 15, 2026.
What the reports do

Each report translates the same market-close options snapshot into a specific lens such as directional bias, premium-selling posture, flow quality, or earnings setup.

How traders use them

Reports are most useful for narrowing the playbook, surfacing entry and risk context, and deciding which raw data page to inspect next.

What to remember

These are interpretation layers, not execution guarantees. Validate the setup against chain liquidity, expected move, and exposure before sizing risk.

If the report conviction and the raw data disagree, slow down and resolve the mismatch before sizing risk.